@article{c58df2fdca3748ed846a7d75993b55ac,
title = "Vitamin D Trajectories from Birth to Early Childhood and Elevated Systolic Blood Pressure during Childhood and Adolescence",
abstract = "Vitamin D deficiency is associated with hypertension in adults. It is unknown to what degree vitamin D status in early life can affect blood pressure (BP) a decade later. This study investigated the effect of vitamin D trajectory through early life on systolic BP (SBP) in childhood. This is a prospective birth cohort study of 775 children enrolled from 2005 to 2012 and followed prospectively up to age 18 years at the Boston Medical Center, Boston, MA. Persistent low vitamin D status is defined as plasma 25(OH)D <11 ng/mL at birth and <25 ng/mL in early childhood. Elevated SBP is defined as SBP ≥75th percentile. Low vitamin D status at birth was associated with higher risk of elevated SBP at ages 3 to 18 years: odds ratio, 1.38; (95% CI, 1.01-1.87) compared to those with sufficient vitamin D. Low vitamin D status in early childhood was associated with a 1.59-fold (95% CI, 1.02-2.46) higher risk of elevated SBP at age 6 to 18 years. Persistent low vitamin D status from birth to early childhood was associated with higher risk of elevated SBP (odds ratio, 2.04; [95% CI, 1.13-3.67]) at ages 3 to 18 years. These results suggest that low vitamin D status and trajectory in early life were associated with increased risk of elevated SBP during childhood and adolescence. Our findings will help inform future clinical and public health strategies for vitamin D screening and supplementation in pregnancy and childhood to prevent or reduce risk of elevated BP across the lifespan and generations.",
keywords = "Vitamin D, blood pressure, cell proliferation, homeostasis, pregnancy",
author = "Guoying Wang and Xin Liu and Bartell, {Tami R.} and Colleen Pearson and Cheng, {Tina L.} and Xiaobin Wang",
note = "Funding Information: The CHS (Children{\textquoteright}s Health Study) is supported in part by the National Institutes of Health (NIH) under grants number R01HD086013 and 2R01HD041702; and by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number R40MC27443 and cooperative agreement UJ2MC31074. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by NIH, HRSA, HHS, or the US Government. Funding Information: The CHS (Children's Health Study) is supported in part by the National Institutes of Health (NIH) under grants number R01HD086013 and 2R01HD041702; and by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number R40MC27443 and cooperative agreement UJ2MC31074. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by NIH, HRSA, HHS, or the US Government. Funding Information: We acknowledge Linda Rosen and the Clinical Data Warehouse (CDW) for the assistance in obtaining relevant clinical information; CDW service is supported by the Boston University{\textquoteright}s Clinical and Translational Institute and National Institutes of Health Clinical and Translational Science Awards (CTSA) Program grant U54-TR001012. In addition, we thank all of the study participants and the Boston Medical Center Labor and Delivery Nursing Staff for their support and help with the study. G. Wang and X. Wang had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Publisher Copyright: {\textcopyright} 2019 American Heart Association, Inc.",
year = "2019",
month = aug,
day = "1",
doi = "10.1161/HYPERTENSIONAHA.119.13120",
language = "English (US)",
volume = "74",
pages = "421--430",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",
}